Skip to main content
Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc. — Investor Relations & Filings

Ticker · VKTX ISIN · US92686J1060 LEI · 529900IVC72YPFA25M37 US Professional, scientific and technical activities
Filings indexed 608 across all filing types
Latest filing 2026-05-26 Declaration of Voting R…
Country US United States of America
Listing US VKTX

About Viking Therapeutics, Inc.

https://vikingtherapeutics.com/

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel therapies for patients suffering from metabolic and endocrine disorders. The company's pipeline is centered on small molecule drug candidates designed to address these conditions.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 97% confidence The document is a Form 8-K current report containing Item 5.07 “Submission of Matters to a Vote of Security Holders,” detailing vote counts for three proposals at the 2026 Annual Meeting. These precise vote tallies and outcomes constitute a declaration of voting results, matching the DVA category.
2026-05-26 English
10-Q - Viking Therapeutics, Inc. (0001607678) (Filer)
Interim / Quarterly Report Q1 2026
2026-04-30 English
SCHEDULE 13G/A - Viking Therapeutics, Inc. (0001607678) (Subject)
Major Shareholding Notification
2026-03-27 English
10-K Filing
Annual Report FY 2025
2026-02-11 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and states that a press release reporting financial results for the fourth quarter and year ended December 31, 2025, is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references a press release. The length is 3893 characters, which is relatively short and consistent with a current report filing rather than a full financial report. According to the classification rules, such a document is best classified as a Regulatory Filing (RNS) because it is a current report filing announcing financial results but does not contain the full financial report or detailed financial data itself.
2026-02-11 English
3 Filing
Director's Dealing
2026-01-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.